A Non-woven Path: Electrospun Poly(lactic acid) Scaffolds for Kidney Tissue Engineering
- 637 Downloads
Chronic kidney disease is a major global health problem affecting millions of people; kidney tissue engineering provides an opportunity to better understand this disease, and has the capacity to provide a cure. Two-dimensional cell culture and decellularised tissue have been the main focus of this research thus far, but despite promising results these methods are not without their shortcomings. Polymer fabrication techniques such as electrospinning have the potential to provide a non-woven path for kidney tissue engineering. In this experiment we isolated rat primary kidney cells which were seeded on electrospun poly(lactic acid) scaffolds. Our results showed that the scaffolds were capable of sustaining a multi-population of kidney cells, determined by the presence of: aquaporin-1 (proximal tubules), aquaporin-2 (collecting ducts), synaptopodin (glomerular epithelia) and von Willebrand factor (glomerular endothelia cells), viability of cells appeared to be unaffected by fibre diameter. The ability of electrospun polymer scaffold to act as a conveyor for kidney cells makes them an ideal candidate within kidney tissue engineering; the non-woven path provides benefits over decellularised tissue by offering a high morphological control as well as providing superior mechanical properties with degradation over a tuneable time frame.
KeywordsKidney tissue engineering Scaffold architecture Electrospinning Primary cells Renal
Chronic kidney disease (CKD) is a major worldwide health problem which attributes to 1.5% of deaths worldwide . Current treatment involves dialysis and eventual transplantation; dialysis is a costly technique which constrains day to day life . In 2016 there were 5275 people on the transplant list in the UK alone , this places huge stresses on health care providers as demand outstrips supply. Recent strategies to overcome these shortcomings in transplants are mainly focused on social policy with a new system of presumed consent being proposed . Additional to this there are new avenues and endeavours in bioartificial kidney devices acting as miniaturised implantable dialysis devices which are showing great promise . Furthermore, kidney tissue engineering is one avenue that could provide a better basis for treatment and understanding of CKD and has the unique potential to help meet the ever-growing demand for organs.
Initial success in kidney tissue engineering have shown potential as a testing platform for nephrotoxicity . Current research has focused on simple microfluidic [7, 8, 9, 10, 11] and co-culture [12, 13] models representing structures such as the proximal tubules [7, 8, 9, 11] or glomerulus [10, 12, 13]; other approaches have included the use of embryonic or induced pluripotent cells cultured on tissue culture plastic creating immature kidney organoids [14, 15, 16]. A key element missing from these approaches is a 3D scaffold capable of providing mechanical strength, architectural cues and structure.
It is well documented that a 3D structure affects many different cell types [17, 18, 19, 20] and could quite possibly be a crucial element of kidney tissue engineering. Decellularised tissue is currently the predominant vehicle for 3D kidney cell culture with impressive advances made [21, 22, 23, 24]. This involves flushing detergent through renal tissue to wash out cells and DNA. This acellular extracellular matrix (ECM) is then recellularized and in some cases has been documented to produce rudimentary urine . However, the decellularisation of tissue is not a simple process and the material left behind is often poorly characterised and mechanically weak [21, 26, 27], added to this the formidable task of recellularization  yielding enough uncertainty that other avenues should be pursued alongside.
Biomaterials such as polymer scaffolds have been investigated for kidney tissue engineering in a limited capacity, predominantly through investigation into hollow fibre bioreactors  but also as a conduit for renal segments . Synthetic polymers, such as PLGA, have also been combined with natural ECM and have shown to enhance biocompatibility and reduce hydrophobicity of scaffolds compared to PLGA alone . The paucity of research in polymer scaffold for kidney tissue engineering leave many avenues unexplored.
Electrospinning is a technique that has been utilised in many areas of tissue engineering to yield non-woven fibres resembling the ECM . The technique produces consistent scaffold properties that can be precise when environmental parameters are finely controlled, including humidity, temperature, polymer concentrations, voltage–power, grounding and flow rate . Morphologies of electrospun scaffolds can also be controlled and can affect how cells behave, larger fibres result in greater cell integration, nanofibers give a better representation of ECM and aligned fibres can induce linear orientation of cells [34, 35, 36]. Techniques such as cryogenic electrospinning have also demonstrated to increase the porosity of scaffolds allowing for greater cell integration . In kidney tissue engineering electrospun collagen has been utilised to model the glomerular capillary wall, with evidence of cell–cell communication . Electrospun polycaprolactone has previously been used for culturing epithelial and endothelial cell and shown to support cell life. Cells were seen to migrate into scaffolds, an outcome which is highly desirable for a multi-cell population required to create an organoid .
We have previously shown the ability of electrospun scaffolds to support a kidney cell line . Here, for the first time to the authors knowledge, we study the growth of a multipopulation of rat primary kidney cells on poly(lactic acid) scaffolds of differing morphologies. With there being a distinct lack of research into polymer scaffold for kidney cells, here we show their intrinsic potential as a microenvironment that can maintain multiple cell phenotypic characteristics.
2 Materials and methods
Poly(lactic acid) (PLA) (Goodfellow, UK) was spun at 3 different percentage weight by volume solutions in 1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP) (Manchester Organics, UK). Small fibres were created from a 10% w/v solution at + 17, − 2 kV with a flow rate of 0.5 ml/h at a needle to mandrel distance of 140 mm, needle bore of 0.4 mm. Medium fibres were created from an 18% w/v solution at + 15, − 4 kV with a flow rate of 4 ml/h at a needle to mandrel distance of 200 mm, needle bore of 0.8 mm. Large fibres were created from a 22% w/v solution at + 16, − 4 kV with a flow rate of 4 ml/h at a needle to mandrel distance of 23 mm, needle bore 0.8 mm. Cryogenic fibres were created using the same parameters but with a mandrel filled with dry ice (− 78.5 °C), topping up with dry ice each hour. The low temperature causes ice crystal deposition on the mandrel, increasing the porosity of scaffolds. After spinning the mandrel is freeze dried for 24 h, leaving behind a cryogenically modified scaffold. All fibres were spun at 250 rpm on to a mandrel covered in aluminium foil with 16 ml of solution used for each scaffold. Electrospun sheets were dried in a fume hood for 24 h to remove residual solvent and cut into 10 mm disks ready for cell seeding.
2.2 Mechanical testing
Mechanical testing was performed using an Instron 3367 (Instron, UK) tensile testing machine. A gauge length of 20 mm and width of 5 mm was used for test pieces and thickness was measured using a digital micrometre. Samples were strained at 50% strain per minute with ultimate tensile strength and incremental Young’s modulus (between 0 and 5% strain in 1% intervals) calculated from an N ≥ 5 independent replicates, as previously described .
2.3 Scanning electron microscopy
Fibres were coated using an Emscope SC500A splutter coater using gold–palladium (60:40). A Hitachi S4700 fuelled emission scanning electron microscope (SEM) (Hitachi) with a 5 kV accelerating voltage and a working distance of 12 mm was used to image scaffolds.
2.4 Primary rat kidney isolation
Kidneys were taken from a 4-week-old female Sprague–Dawley rat and washed in Krebs–Ringer bicarbonate buffer supplemented with 1% antibiotic/antimycotic (anti/anti). The renal capsule and adjacent connective tissue were removed, and kidneys washed before placing in a falcon tube containing Krebs–Ringer and anti/anti. Kidneys were transferred to a cell culture hood and minced in a petri-dish using a scalpel. Minced tissue was incubated in collagenase from clostricium histolyticum (Sigma-Aldrich, UK) at a concentration of 0.625 mg/ml for 30 min at 37 °C, 2 kidneys per 12.5 ml. Following, the solution was filtered through a 70 µm cell strainer and neutralised with Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 1% anti/anti and 10% foetal bovine serum (FBS). The solution was centrifuged at 500 g for 5 min and the supernatant discarded. Cells were resuspended in a 1:1 ratio of DMEM and keratinocyte serum-free media (KSFM) supplemented with 25 mg bovine pituitary extract and 2.5 µg epidermal growth factor, 5% FBS and 1% anti/anti. Cells were plated with 2 kidneys in 5 T175 flasks and cultured for 24 h before washing with PBS and replenishing media. Protocol adapted from He et al.  and Joraku et al. .
2.5 Cell seeding
Scaffolds were sterilised in 2-propanol for 30 min before washing 3 times in phosphate buffered saline (PBS). Trypsin–EDTA 0.05% was used to lift cells from culture flasks, neutralised in cell culture media and centrifuged at 500 g for 5 min. In 12 well suspension plates, 400,000 cells (p1) were seeded to each scaffold in 50 µl media and left to attach for an hour before adding an additional 400 µl media. Cultures were incubated at 37 °C in 5% CO2 for 3 and 7 days and media was changed every 2 days.
2.6 Cell viability
A CellTitre-Blue® assay (Promega, UK) was used to evaluate cell viability. Scaffolds were placed in a new 48 well suspension plate and washed 3 times in PBS, 480 µl of stock solution (5:1, media/assay) was added to each scaffold and incubated for 2 h. Fluorescence was read using a microplate reader (Modulus II 9300-062, Turner Biosystems) at Ex 520 nm Em 580–640 nm, N = 4 independent replicates. A standard curve was used to estimate cell number.
2.7 DNA quantification
Scaffolds were washed 3 times in PBS and freeze dried for 24 h. Each scaffold was incubated within an ultrasonic bath (6 litre Cavitek Digital, The Allendale Group, UK) in 300 µl of a 2.5 units/ml papain digest solution, 5 mM cysteine HCL and 5 mM EDTA in PBS (all reagents from Sigma Aldrich, UK) at 60 °C for 24 h with periodic sonication. Total DNA content of the samples was calculated using a Quant-iT™ PicoGreen® assay kit (ThermoFisher, UK) as per the manufacturers’ instructions. Fluorescence was read using a microplate reader at Ex 490 nm Em 510–570 nm, N = 4 independent replicates.
2.8 Immunohistochemistry imaging
Scaffold were washed 3 times in PBS and fixed in a 3.7% (v/v) solution of formalin and PBS for 10 min, followed by 3 additional washes. Permeabilization was performed using a 0.05% TWEEN in a 10 mM Tris and 1 mM MEDTA solution, scaffolds were incubated in 300 µl for 1 h before washing 3 times.
Scaffolds were dehydrated in 2-propanol solutions graduating from 30 to 100% for 10 min in each. Scaffolds were then left in a solution of 2-propanol and polyester wax (1:1) at 50 °C overnight. Next, scaffolds were placed in polyester wax for 3 h and then fresh wax overnight at 50 °C. Scaffold were halved and blocked for sectioning into 35 µm slices.
2.9 Statistical analysis
Data was tested using Levene’s test for equal variance before statistical analysis was performed in order to select appropriate tests. Electrospun fibre diameters were analysed using a one-way ANOVA with post hoc Games-Howel test. CellTitre blue and mechanical data was analysed using a one-way ANOVA with post hoc Tukey pairwise comparison; as data had a slight positive skew it was transformed by natural log giving a more normal distribution. Data on electrospun fibres is presented as mean ± standard deviation, all graphs are presented as mean ± 95% confidence interval, circles on graphs denote individual data points.
3.1 Electrospun fibres
Mechanical properties and physical properties of PLA scaffolds
Fibre diameter, µm
0.88 ± 0.16
2.46 ± 0.43
3.71 ± 0.36
3.30 ± 0.17
Scaffold thickness, µm
193 ± 5.16
270 ± 8.63
1375 ± 160
218 ± 13.0
Young’s modulus at % Strain, MPa
2.84 ± 1.41
5.78 ± 1.51
0.57 ± 0.15
7.15 ± 1.97
6.53 ± 0.85
6.40 ± 1.49
0.72 ± 0.16
6.61 ± 0.81
5.34 ± 0.91
9.13 ± 1.12
1.13 ± 0.30
8.69 ± 1.48
4.76 ± 0.54
7.48 ± 0.94
1.31 ± 0.21
6.87 ± 1.62
2.84 ± 0.67
4.22 ± 0.62
0.81 ± 0.14
3.59 ± 1.13
5.05 ± 0.52
7.31 ± 0.84
1.01 ± 0.20
7.14 ± 1.04
Ultimate tensile strength, MPa
3.25 ± 0.21
4.25 ± 0.31
0.87 ± 0.17
4.02 ± 0.56
The Young’s modulus at 0–5% strain was analysed by one-way ANOVA, this analysis showed a significant difference between scaffolds F(3,21) = 103.32, p = 0, Table 1. Post hoc analysis using Tukey test showed that all scaffolds at 0–5% strain, except medium compared to large fibres, were significantly different to each other, p < 0.001. A similar trend follows with analysis of ultimate tensile strength, F(3,21) = 133.31, p = 0. Post-hoc analysis shows all scaffold are significantly different from each other except large and medium scaffolds, p < 0.05. Notably, randomly spun scaffolds reach a peak Young’s modulus at 2–3% strain whereas cryogenic spinning increases the percentage strain at which Young’s modulus is highest to 3–4% strain.
3.2 Cell viability and DNA quantification
Emphasis so far in kidney tissue engineering has been on 2D cell culture, which has shown considerable progression in recent years [15, 42, 43]. However, cells within the Kidney do not exist within the two dimensional axis of cell culture plastic, with greater amounts of research underlining the importance of a 3D structure [17, 44]. 3D kidney tissue engineering has focused on the use of decellularised tissue with promising results [25, 45]; this method is not without its shortcomings, with issues surrounding decontamination  and a lack of a standardized approach to decellularisation leading to a variation between scaffolds [21, 26, 27]. Decellularised tissue brings favourable physical and chemical characteristics to help support cells and control physiology , but as cell produce their own ECM a synthetic scaffold can provide an excellent foundation to build upon [48, 49]. Polymer scaffolds offer many benefits over decellularised tissue as their manufacture can be highly controlled, as well as providing superior mechanical properties with degradation over a tuneable time frame [31, 33, 50].
Our electrospun fibres demonstrate the control with which polymer scaffold are fabricated having a standard deviation in fibre diameter and Young’s modulus (0–5% strain) of less than 20% in all cases, Table 1. The increase in porosity of 97.3% gained from cryogenic electrospinning, demonstrated in the dramatic increase in thickness of the scaffold spun under the same conditions as large fibres, comes at the cost of mechanical strength; fibres had an UTS 5 times lower despite spinning under the same parameters, this follows a similar trend to previous works [37, 51]. The variation seen in scaffold thickness may be influenced by a decrease in humidity due to the low temperature as humidity is known to effect the diameter of electrospun fibres , the low temperature of the mandrel may also reduce the ambient temperature increasing the viscosity of the polymer solution . Interestingly, Young’s modulus peaks in normally spun scaffolds at 2–3% strain but at 3–4% for cryogenically spun fibres this is probably due the nature of the scaffold and looser packing in cryogenic fibres allowing for more strain in the scaffold before all fibres are in tension. Cryogenic scaffold can be controlled further thought monitoring the humidity of spinning conditions .
There is great scope for the use of polymer scaffolds within kidney tissue engineering. Our work follows on from the limited published research into the use of kidney cells with electrospun scaffolds [13, 30, 55]. We have previously shown that electrospun PCL can be used to grow a kidney cells line, and highlighted the effects of morphological differences in scaffolds . Here we have gone further, using RPK cells and demonstrating the survival of key cell types of this multi-cell population, Fig. 4. Although, our results regarding fibre diameter and its influence on cell behaviour are not conclusive, it has been shown to have major implication in previous studies [39, 56, 57, 58]. There is some disparity between our data for CellTitre blue and DNA quantification, this is possibly as a result of the much greater porosity gained from cryogenic electrospinning where unattached cells become trapped within the scaffold. It does however show that viable cells, shown through CellTitre blue, are surviving over time as DNA content remained constant.
An important factor to consider here is scaffold chemistry, we have demonstrated that PLA facilitates primary cell survival but it is not optimised for kidney cells. Survival on polymer scaffold could be vastly improved with optimisation through such techniques as microarray [59, 60, 61] allowing for analysis of cell interaction with many polymer types in a high-throughput manner. Other popular optimisation techniques include integrating ECM components with polymer scaffold to produce a hybrid deriving benefits from both, this method has shown to improve the mechanical properties of the scaffold whilst increasing cell interaction . Further novel techniques have used a sacrificial cell layer to produce an ECM layer on top of the polymer scaffold before decellularisation, maintaining the initial mechanical characteristics . Some of these methods may bring about a greater interaction between cells and scaffold and could provide more conclusive evidence on the type of architecture that is most favourable to kidney cells.
We did not see organisation of cells into kidney like structures and more research is needed over a longer time frame to assess for elements of self-organisation. The ability of embryonic and induced pluripotent stem cells to self-organise is well documented [6, 68], and these cells of greater physiological and clinical relevance are the next logical step for polymer scaffolds in kidney tissue engineering. Our view is that polymer scaffolds have the ability to act as a conveyor for kidney cells, allowing kidney cells to self-organise before implantation where a full organ can mature. We feel this is a reasonable alternative to the implantation of decellularised organs, and has previously been highlighted as a potential avenue .
We have demonstrated here the variation of architectures that can be created from a single polymer and solvent solution by electrospinning. This is just one polymer in many that could be used in kidney tissue engineering. Electrospun polymer scaffolds have the ability to create a range of different architectures and should be considered for further investigation in kidney tissue engineering due to their: ability to host a multi-population of cells, biocompatibility, reproducibility, good mechanical properties and 3D structure. This is a new non-woven path within kidney tissue engineering and one that should be explored further.
This research is funded by an Engineering and Physical Sciences Research Council (EPSRC) Doctoral Training Partnership (DTP) Studentship and MRC computational and chemical biology of the stem cell niche Grant (CCBN) MR/L012766/1. We would like the thank Prof. Alistair Elfick for use of the lab facility, Stephen Mitchell at the BioSEM facility and Dr. David Kelly at the centre optical instrument laboratory (COIL) for use of their microscope.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
There are no animal experiments carried out for this article.
- 2.Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, et al. US renal data system 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2015;66:A1–7, S1–305. https://doi.org/10.1053/j.ajkd.2015.05.001.
- 3.NHS Blood and Transplant. Organ donation and transplantation. Activity Report 2013–2014.Google Scholar
- 9.Kim S, LesherPerez SC, Kim BC, Yamanishi C, Labuz JM, Leung B, et al. Pharmacokinetic profile that reduces nephrotoxicity of gentamicin in a perfused kidney-on-a-chip. Biofabrication. 2016;8:15021.Google Scholar
- 10.Zhou M, Zhang X, Wen X, Wu T, Wang W, Yang M, et al. Development of a functional glomerulus at the organ level on a chip to mimic hypertensive nephropathy. Sci Rep. 2016;6:31771.Google Scholar
- 11.Homan KA, Kolesky DB, Skylar-Scott MA, Herrmann J, Obuobi H, Moisan A, et al. Bioprinting of 3D convoluted renal proximal tubules on perfusable chips. Sci Rep. 2016;6:34845.Google Scholar
- 12.Li M, Corbelli A, Watanabe S, Armelloni S, Ikehata M, Parazzi V, et al. Three-dimensional podocyte–endothelial cell co-cultures: assembly, validation, and application to drug testing and intercellular signaling studies. Eur J Pharm Sci. 2016;86:1–12.Google Scholar
- 14.Xia Y, Sancho-Martinez I, Nivet E, Rodriguez Esteban C, Campistol JM, Izpisua Belmonte JC. The generation of kidney organoids by differentiation of human pluripotent cells to ureteric bud progenitor–like cells. Nat Protoc. 2014;9:2693–704.Google Scholar
- 15.Morizane R, Lam AQ, Freedman BS, Kishi S, Valerius MT, Bonventre JV. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol. 2015;33:1193–200.Google Scholar
- 16.Xinaris C, Benedetti V, Rizzo P, Abbate M, Corna D, Azzollini N, et al. In vivo maturation of functional renal organoids formed from embryonic cell suspensions. J Am Soc Nephrol. 2012;23:1857–68.Google Scholar
- 23.Bonandrini B, Figliuzzi M, Papadimou E, Morigi M, Perico N, Casiraghi F, et al. Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells. Tissue Eng Part A. 2014;20:1486–98.Google Scholar
- 24.Petrosyan A, Orlando G, Peloso A, Wang Z, Farney AC, Rogers J, et al. Understanding the bioactivity of stem cells seeded on extracellular matrix scaffolds produced from discarded human kidneys : a critical step towards a new generation bio-artificial kidney. CellR4 Repair Replace Regen Reprogram. 2015;3:e1401.Google Scholar
- 25.Song JJ, Guyette JP, Gilpin SE, Gonzalez G, Vacanti JP, Ott HC. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med. 2013;19:646–51.Google Scholar
- 46.Poornejad N, Nielsen JJ, Morris RJ, Gassman JR, Reynolds PR, Roeder BL, et al. Comparison of four decontamination treatments on porcine renal decellularized extracellular matrix structure, composition, and support of renal tubular epithelium cells. J Biomater Appl. 2016;30:1154–67.CrossRefPubMedGoogle Scholar
- 55.Burton TP, Callanan A. Engineering the kidney: the effects of scaffold architecture. Eur Cells Mater Suppl 4. 2016;32:13.Google Scholar
- 61.Hook AL, Chang CY, Yang J, Scurr DJ, Langer R, Anderson DG, et al. Polymer microarrays for high throughput discovery of biomaterials. J Vis Exp. 2012;59:e3636.Google Scholar
- 69.Kim S, Fissell WH, Humes HD, Roy S. Current strategies and challenges in engineering a bioartificial kidney. Front Biosci (Elite Ed). 2015;7:215–28.Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.